Quinidine:

Class Ia Antiarrhythmic

   

 
 

This is the prototype class Ia drug, however, Quinidine is now being used less in favor of other drugs which have less potential for severe side effects.  Quinidine decreases conduction velocity, automaticity, and prolongs the myocardial action potential.  Both peripheral and myocardial a-receptors are inhibited by Quinidine which can, of course, lead to decreased vascular tone and hypotension.  Muscarinic receptors are also inhibited, leading to a vagolytic increase in sympathetic tone that can ­ HR via the sinus node, and  increase AV node conduction causing a faster ventricular rate in A fib/flutter, and greater risk of other arrthythmias.  Quinidine does however slow the "fast" retrograde accessory pathway in AV nodal tachycardias, and slows the ventricular response to WPW syndrome.  

 

Dose: Complex... deferred!  

 

Side Effects: Lots!

 

Contraindicated: in pts with IVCDs, dig toxicity, escape rhythms, myasthenia gravis, other stuff I'm sure!

« LAST DRUG

NEXT DRUG »

Copyright 2009, Samos Alixopulos, ICU RN